The Position
This is a pivotal leadership role within our UK Pharma Commercial team. You join at a moment of radical healthcare transformation — where market access, government affairs, and health economics converge to determine whether life‑changing therapies reach the patients who need them. You lead a multidisciplinary function that shapes the UK’s position as a priority destination for global pharmaceutical investment.
The Opportunity
Shape the future of UK pricing and reimbursement by leading the organisation’s strategy across NICE, SMC, and AWMSG — ensuring our portfolio remains commercially viable and accessible to patients
Lead high‑stakes negotiations for Commercial Access Agreements that protect and grow a billion‑pound revenue stream through sustainable, innovative funding models
Influence government policy at the highest levels maintaining strategic relationships across the Department of Health and Social Care, HM Treasury, and the broader political landscape
Build a world‑class Access engine that serves as the gold standard for our global headquarters — proving that the UK is a priority launch market
Drive health equity and system transformation by leading initiatives that improve patient outcomes, enhance population health, and reduce per‑capita costs in partnership with the NHS
Pioneer innovative access models including outcome‑based agreements, value‑based pricing, and real‑world evidence frameworks that can be exported globally
Who you are
You bring extensive senior leadership in market access, health economics, or government affairs within the pharmaceutical or life sciences sector
You have deep expertise in UK HTA processes and the commercial mechanics of industry‑government pricing frameworks
You are a proven political advocate, comfortable engaging at ministerial and senior civil servant level to shape policy outcomes
You are an enterprise thinker who balances access decisions against commercial, medical, and supply chain considerations across a complex portfolio
You lead with purpose — translating strategic patience into tactical urgency to deliver patient access today while building frameworks for tomorrow
Preferred
Experience navigating the post‑Brexit regulatory and trade landscape as it impacts pharmaceutical operations
Background in Real‑World Evidence generation and its application to HTA submissions and lifecycle management
International or global headquarters experience demonstrating cross‑market strategic influence
The statements herein are intended to describe the general nature and level of work being performed by employees, and are not to be construed as an exhaustive list of responsibilities, duties, and skills required of personnel so classified. Furthermore, they do not establish a contract for employment and are subject to change at the discretion of Roche Products Ltd. At Roche Products we believe diversity drives innovation and we are committed to building a diverse and flexible working environment. All qualified applicants will receive consideration for employment without regard to race, religion or belief, sex, gender reassignment, sexual orientation, marriage and civil partnership, pregnancy and maternity, disability or age. We recognise the importance of flexible working and will review all applicants’ requests with care. At Roche difference is valued and we are proud to be an equal opportunity employer where you are encouraged to bring your whole self to work.
#J-18808-Ljbffr…